Table 2.
Median DNA methylation levels by global features across tissues
| # CpGs (Blood/Brain) | T1 | T2 | Brain | p Δ | |
|---|---|---|---|---|---|
| Island features | |||||
| Island | 135,303/135,303 | 0.059 | 0.060 | 0.058 | <0001 |
| North shore | 55,328/55,328 | 0.481 | 0.485 | 0.442 | <0001 |
| South shore | 43,325/43,325 | 0.466 | 0.471 | 0.415 | <0001 |
| North shelf | 20,732/20,732 | 0.845 | 0.846 | 0.826 | <0001 |
| South shelf | 18,409/18,409 | 0.847 | 0.848 | 0.830 | <0001 |
| Gene features | |||||
| TSS1500 | 60,703/60,703 | 0.172 | 0.176 | 0.161 | <0001 |
| TSS200 | 47,242/47,242 | 0.048 | 0.049 | 0.048 | .031 |
| 5’UTR | 37,987/37,987 | 0.141 | 0.144 | 0.135 | <0001 |
| 1stExon | 20,239/20,239 | 0.062 | 0.063 | 0.059 | .002 |
| Gene body | 141,917/141,917 | 0.817 | 0.819 | 0.755 | <0001 |
| 3’UTR | 15,188/15,188 | 0.853 | 0.853 | 0.815 | <0001 |
| Chromatin structure* | |||||
| 1_TssA | 60,614/125,965 | 0.039 | 0.040 | 0.048 | <0001 |
| 2_TssAFlnk | 41,806/21,400 | 0.093 | 0.095 | 0.187 | <0001 |
| 3_TxFlnk | 29,974/872 | 0.037 | 0.038 | 0.497 | <0001 |
| 4_Tx | 28,060/23,942 | 0.895 | 0.895 | 0.863 | <0001 |
| 5_TxWk | 33,593/55,988 | 0.876 | 0.877 | 0.835 | <0001 |
| 6_EnhG | 4,486/4399 | 0.856 | 0.858 | 0.701 | <0001 |
| 7_Enh | 23,797/24,161 | 0.741 | 0.746 | 0.586 | <0001 |
| 8_ZNF/Rpts | 894/702 | 0.852 | 0.851 | 0.673 | <0001 |
| 9_Het | 2,119/1,528 | 0.805 | 0.805 | 0.806 | 0.775 |
| 10_TssBiv | 3,872/12,473 | 0.064 | 0.066 | 0.087 | <0001 |
| 11_BivFlnk | 9,281/4,212 | 0.090 | 0.094 | 0.091 | 0.008 |
| 12_EnhBiv | 9,381/3,645 | 0.146 | 0.151 | 0.186 | <0001 |
| 13_ReprPC | 15,708/17,536 | 0.254 | 0.263 | 0.264 | <0001 |
| 14_ReprPCWk | 39,455/36,929 | 0.684 | 0.683 | 0.804 | <0001 |
| 15_Quies | 117,092/86,380 | 0.841 | 0.841 | 0.848 | <0001 |
1: Active TSS; 2: Flanking Active TSS; 3: Transcription at gene 5’ and 3’; 4: Strong transcription; 5: Weak transcription; 6: Genic enhancers; 7: Enhancers; 8: ZNF genes & repeats; 9: Heterochromatin; 10: Bivalent/Poised TSS; 11: Flanking Bivalent TSS/Enh: 12: Bivalent Enhancer; 13: Repressed PolyComb; 14: Weak Repressed PolyComb; 15: Quiescent/Low. Detailed description is reported previously [17].
Each p-value was derived from a non-parametric Kruskal-Wallis test which compares the difference of median methylation levels between T1, T2 and brain.